HAWTHORNE, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (NASDAQ: ACOR) today announced that it will host an analyst and investor breakfast on April 14, 2007, at the American Academy of Neurology (AAN) annual meeting. The Company, along with its scientific collaborators, will present highlights from its preclinical programs. Moses Rodriguez, M.D., Professor of Neurology and Immunology at Mayo Clinic College of Medicine will present an overview of the remyelinating antibody program, and Douglas E. Vaughan, M.D., C Sidney Burwell Professor of Medicine and Professor of Pharmacology and Chief, Division of Cardiovascular Medicine at Vanderbilt University will present data from the neuregulins development program.
